Interest Expense in USD of RVL Pharmaceuticals plc from Q3 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
RVL Pharmaceuticals plc quarterly/annual Interest Expense history and change rate from Q3 2017 to Q2 2023.
  • RVL Pharmaceuticals plc Interest Expense for the quarter ending 30 Jun 2023 was $13K, a 98.7% decline year-over-year.
  • RVL Pharmaceuticals plc Interest Expense for the twelve months ending 30 Jun 2023 was $1.19M, a 70.2% decline year-over-year.
  • RVL Pharmaceuticals plc annual Interest Expense for 2022 was $3.11M, a 2.44% increase from 2021.
  • RVL Pharmaceuticals plc annual Interest Expense for 2021 was $3.04M, a 25.9% decline from 2020.
  • RVL Pharmaceuticals plc annual Interest Expense for 2020 was $4.1M, a 31.9% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

RVL Pharmaceuticals plc Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1.19M $13K -$965K -98.7% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $2.15M $26K -$959K -97.4% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $3.11M $15K -$1.27M -98.8% 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2023
Q3 2022 $4.38M $1.13M +$397K +54% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $3.98M $978K +$484K +98% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $3.5M $985K +$464K +89.1% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $3.04M $1.29M +$3.57M 01 Oct 2021 31 Dec 2021 10-K 20 Mar 2023
Q3 2021 -$529K $735K -$336K -31.4% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$193K $494K -$745K -60.1% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $552K $521K -$3.54M -87.2% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $4.1M -$2.28M +$5.26M +69.8% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 -$1.17M $1.07M -$3.43M -76.2% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $2.26M $1.24M -$3.31M -72.8% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 $5.58M $4.06M -$437K -9.71% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $6.01M -$7.54M -$12.9M -240% 01 Oct 2019 31 Dec 2019 8-K 08 Sep 2021
Q3 2019 $19M $4.5M -$807K -15.2% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $19.8M $4.55M -$689K -13.2% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 $20.4M $4.5M -$342K -7.06% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q4 2018 $20.8M $5.39M 01 Oct 2018 31 Dec 2018 10-K 19 Mar 2020
Q3 2018 $5.31M -$1.99M -27.3% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $5.24M 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 $4.84M 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q3 2017 $7.3M 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018

RVL Pharmaceuticals plc Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.11M +$74K +2.44% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2023
2021 $3.04M -$1.06M -25.9% 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2023
2020 $4.1M -$1.92M -31.9% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 $6.01M -$14.8M -71.1% 01 Jan 2019 31 Dec 2019 8-K 08 Sep 2021
2018 $20.8M -$8.26M -28.4% 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020
2017 $29.1M 01 Jan 2017 31 Dec 2017 8-K 20 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.